Abstract
The 2021 American Society of Clinical Oncology (ASCO) guideline for the management of salivary gland cancer offers 47 evidence‐based recommendations on preoperative evaluations, diagnostic and therapeutic surgical procedures, radiotherapy, systemic therapy, follow‐up evaluations, and recurrent metastatic disease. The ASCO guideline provides a framework and the best current evidence for managing the care of patients with salivary gland malignancies from diagnosis to treatment, and it endorses fine‐needle aspiration biopsy and the new Milan System for Reporting Salivary Gland Cytopathology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
